Literature DB >> 32493734

New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response.

Sirada Panupattanapong1, Elizabeth B Brooks2.   

Abstract

In April 2020, data began emerging on Kawasaki-like syndrome and hyperinflammatory response in children with COVID-19. Since then, much has been published on the presentation of COVID-19 in pediatric patients, including its association with Kawasaki disease and the multisystem inflammatory syndrome in children (MIS-C). However, questions still remain regarding the risk factors, pathogenesis, prognosis, and specific therapy for these manifestations of COVID-19.
Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

Entities:  

Year:  2020        PMID： 32493734     DOI： 10.3949/ccjm.87a.ccc039

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  15 in total

Review 1.  Diagnosis and Acute Management of COVID-19 and Multisystem Inflammatory Syndrome in Children.

Authors:  Teresa B Kortz; Emilia Connolly; C Lee Cohen; Rebecca E Cook; Jennifer A Jonas; Michael S Lipnick; Niranjan Kissoon
Journal:  Pediatr Emerg Care       Date:  2021-10-01       Impact factor: 1.602

2.  SARS-CoV-2 Infectivity and Neurological Targets in the Brain.

Authors:  Walter J Lukiw; Aileen Pogue; James M Hill
Journal:  Cell Mol Neurobiol       Date:  2020-08-25       Impact factor: 5.046

3.  Cutaneous Manifestations of COVID-19: A Systematic Review.

Authors:  Harjas Singh; Harleen Kaur; Kanhaiya Singh; Chandan K Sen
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-10-19       Impact factor: 4.730

Review 4.  Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease.

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Leanne Groban
Journal:  Clin Sci (Lond)       Date:  2020-10-16       Impact factor: 6.876

5.  Professional Obligations of Clinicians and Institutions in Pediatric Care Settings during a Public Health Crisis: A Review.

Authors:  Naomi T Laventhal; Ratna B Basak; Mary Lynn Dell; Nanette Elster; Gina Geis; Robert C Macauley; Mark R Mercurio; Douglas J Opel; David I Shalowitz; Mindy B Statter; Douglas S Diekema
Journal:  J Pediatr       Date:  2020-06-23       Impact factor: 4.406

6.  High incidence of stroke and mortality in pediatric critical care patients with COVID-19 in Peru.

Authors:  Alvaro Coronado Munoz; Jaime Tasayco; Willy Morales; Luis Moreno; David Zorrilla; Angie Stapleton; Patricia Pajuelo; Giuliana Reyes; Matilde Estupiñan; Ricardo Seminario; Manuel Ortiz; Jesús Domínguez
Journal:  Pediatr Res       Date:  2021-05-03       Impact factor: 3.953

7.  Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children.

Authors:  Fatih Haslak; Kenan Barut; Cansu Durak; Ayten Aliyeva; Mehmet Yildiz; Vafa Guliyeva; Sevki Erdem Varol; Sinem Oral Cebeci; Fatih Aygun; Yusuf Ziya Varli; Abdulrahman Ozel; Sertac Hanedan Onan; Ulkem Kocoglu; Meltem Erol; Fatih Karagozlu; Nujin Ulug; Reyhan Dedeoglu; Sezgin Sahin; Amra Adrovic; Funda Oztunc; Ozgur Kasapcopur
Journal:  Clin Rheumatol       Date:  2021-06-05       Impact factor: 2.980

Review 8.  Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view.

Authors:  Hany Simon Junior; Tania Miyuki Shimoda Sakano; Regina Maria Rodrigues; Adriana Pasmanik Eisencraft; Vitor Emanoel Lemos de Carvalho; Claudio Schvartsman; Amelia Gorete Afonso da Costa Reis
Journal:  J Pediatr (Rio J)       Date:  2020-09-11       Impact factor: 2.990

Review 9.  Exploring the causes of mild COVID-19 involvement in pediatric patients.

Authors:  A Naserghandi; R Saffarpour; S F Allameh
Journal:  New Microbes New Infect       Date:  2020-08-11

10.  Kawasaki-like disease in children with COVID-19.

Authors:  Ummusen Kaya Akca; Selman Kesici; Yasemin Ozsurekci; Hayrettin Hakan Aykan; Ezgi Deniz Batu; Erdal Atalay; Selcan Demir; Erdal Sag; Dogus Vuralli; Benan Bayrakci; Yelda Bilginer; Seza Ozen
Journal:  Rheumatol Int       Date:  2020-09-16       Impact factor: 3.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.